Brokerages Set Clarivate PLC (NYSE:CLVT) Price Target at $3.22

Shares of Clarivate PLC (NYSE:CLVT) have received a consensus recommendation of “Reduce” from the eight ratings firms that are covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $3.2333.

CLVT has been the topic of a number of recent research reports. Barclays lifted their target price on Clarivate from $2.40 to $2.50 and gave the company an “underweight” rating in a research report on Tuesday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research note on Wednesday, June 24th. Finally, Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd.

Institutional Investors Weigh In On Clarivate

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Personal CFO Solutions LLC bought a new stake in Clarivate during the 1st quarter worth about $30,000. FreeGulliver LLC bought a new position in shares of Clarivate in the 1st quarter valued at about $30,000. Principal Financial Group Inc. acquired a new stake in shares of Clarivate in the first quarter valued at about $32,000. M&T Bank Corp acquired a new stake in shares of Clarivate in the fourth quarter valued at about $34,000. Finally, Parallel Advisors LLC raised its holdings in Clarivate by 94.2% during the first quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock worth $35,000 after acquiring an additional 6,687 shares in the last quarter. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Clarivate Price Performance

Shares of NYSE CLVT opened at $2.19 on Friday. The company has a fifty day moving average price of $2.40 and a 200 day moving average price of $2.54. The firm has a market cap of $1.40 billion, a PE ratio of -10.45 and a beta of 1.38. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. Clarivate has a 1-year low of $1.66 and a 1-year high of $4.77.

Clarivate (NYSE:CLVT) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.04. The firm had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The company’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter last year, the business posted $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Research analysts predict that Clarivate will post 0.65 earnings per share for the current fiscal year.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.